Access Insights 2024: The Growth of Specialty Pharmacy
Albert Thigpen, co-founder, Talentwise Consulting, explains how the specialty pharmacy sector has evolved over the years.
Access Insights 2024: Pharmacy Benefit Management Trends
Albert Thigpen, co-founder, Talentwise Consulting, discusses the valuable buckets pertaining to the PBM space.
Access Insights 2024: Reassessing Pricing and Commercialization Approaches
Albert Thigpen, co-founder, Talentwise Consulting, explains how to use these tactics in order to anticipate the future US healthcare policy environment.
Access Insights 2024: Key Nuggets Surrounding the Chess Endgame
Albert Thigpen, co-founder, Talentwise Consulting, offers highlights of the drug commercialization panel that he participated in.
Access Insights 2024: The State of Retail Pharmacy
Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses key takeaways of the breakout session.
Access Insights 2024: Playing the Chess Endgame
A panel dives into the current and future outlook of healthcare policies.
Access Insights 2024: Financial Headwinds and Tailwinds to Commercialization
Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses the key takeaways of this year's keynote speech.
Access Insights 2024: Practicing Proactivity by Mapping Out Future Chessboard Moves
Session dives into how healthcare policy implementation impacts stakeholders long-term.
Access Insights 2024: Notable Breakout Sessions
William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.
Access Insights 2024: Analyzing Drug Pricing and Reimbursement Data Amid a New Wave of CMS Price Requirements
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
Access Insights 2024: Playing the Chess Endgame: Healthcare Policies Targeting Drug Commercialization
William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses breakout session and the impact of healthcare policies on manufacturing and commercialization.
Access Insights 2024: Commercialization’s Financial Headwinds and Tailwinds
The conference’s opening keynote sets the scene for 2025 and the years to come.
Pharma KOLs to Unite at Access Insights Conference 2024
This year’s conference—taking place in Washington, DC— will prioritize the tackling of business, economic, and healthcare policy obstacles when it comes to decision marking and net revenue optimization.
Access Insights 2023: Bill Roth Talks 2024 Being the Year of "Who Moved my Prescription"
Blue Fin Group exec speaks on his upcoming feature.
Access Insights 2023: Bill Roth Offers Insights for Chief Commercial Officers Planning a Profitable 3-5 Year Lifecycle
Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.
Access Insights 2023: Bill Roth Provides an Overview of his Keynote Speech, Fight for the Dollar
SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.
Access Insights 2023: Price Transparency Data in Pharma
Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.
Access Insights 2023: A View from DC
Conference presentation explores groundbreaking topics impacting the pharma industry.
Access Insights 2023: Andrew Brownlee Discusses How the 340B Landscape Will Continue to Evolve Moving Forward
Director of Berkeley Research Group explains changes to 340B moving forward.
Access Insights 2023: Andrew Brownlee Discusses How Manufacturers Calculate 340B Prices
Berkeley Research Group executive speaks about the role of manufacturers in 340B pricing.
Access Insights 2023: Andrew Brownlee Discusses Things to Expect in his "340B Lessons from the Field" Presentation
Berkeley Research Group Director discusses what to expect at his upcoming session.
Access Insights 2023: Biosimilars, Specialty Generics’ Impact on Sites of Care
Session explores how on-market products have done, and what to expect from new biosimilars.
Access Insights 2023: The Pharmacy of the Future
Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.
Access Insights 2023: Fight for the Dollar
Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.